Cardiology
|
December 17, 2024

How to Lower Apolipoprotein B (ApoB) Naturally: A Comprehensive Guide

Medically Reviewed by
Updated On
December 23, 2024

Atherosclerosis, the leading contributor to heart disease and stroke, accounts for nearly 50% of deaths in Western societies. This life-threatening condition is driven by the buildup of fatty plaques in the arteries, a process closely linked to apolipoprotein B (ApoB).Β 

Unlike standard cholesterol tests, which measure LDL, HDL, and triglycerides, ApoB provides a more comprehensive assessment of cardiovascular risk.Β 

This article provides a comprehensive review of natural ways to lower your ApoB. Understanding your ApoB levels through blood tests may provide insights into your potential risk for atherosclerotic cardiovascular disease (ASCVD) and support discussions about lifestyle changes or medical treatments.

[signup]

What Is Apolipoprotein B (ApoB)?

Lipids, such as cholesterol, are fatty substances that are not water-soluble. As they are unable to dissolve in water-rich plasma, lipids are transported in the blood via proteins called lipoproteins which carry cholesterol components in their core and on their outer surface.Β 

A cholesterol panel tests for specific lipoproteins such as:

Apolipoproteins are proteins that encase lipoproteins, helping to provide structure to lipids as they travel throughout the blood. Apolipoprotein B (ApoB) is a type of apolipoprotein that is attached to the lipoproteins LDL, VLDL, and lipoprotein (a), all of which contribute to the formation of plaques in the arteries.Β 

Lipoproteins typically pass through arterial walls as part of normal transport in the bloodstream. However, apolipoprotein B may become trapped within the arterial wall, contributing to plaque formation, a process associated with atherosclerosis.Β 

As more plaque builds up within the arterial wall, the narrower the artery becomes. If they grow large enough, these plaques can eventually cut off the flow of blood in an artery. They can also break into pieces and be carried downstream into smaller arteries where they lodge, potentially causing a heart attack or stroke. Because of its association with atherosclerosis, ApoB can be a useful marker for an individual’s risk for ASCVD.Β 

Lab Testing for Apolipoprotein B

ApoB is measured using a blood test. It is often added to a larger panel that assesses a person’s overall cholesterol profile. The components of a basic cholesterol panel often include:

  • Total cholesterol: the sum of HDL and LDL in the blood.Β 
  • Triglycerides: fat stores that are created when caloric intake is in excess, especially sugars and alcohol. Can be a risk factor for cardiovascular disease if elevated.Β 
  • HDL-C: often referred to as β€œgood cholesterol”, this lipoprotein is associated with the breakdown and removal of cholesterol in the arteries.
  • LDL-C: often referred to as β€œbad cholesterol”, too much LDL can lead to plaque formation in the arteries.

Although a typical panel looks at LDL-C, it does not measure all the different types of atherosclerotic lipoproteins. Therefore ApoB can be added to more comprehensively assess an individual’s risk for cardiovascular disease. Elevated ApoB levels may indicate a higher amount of lipoproteins associated with plaque formation in the body.

Typical reference ranges for serum ApoB vary, but generally, an ApoB of less than 90 mg/dL is a recommended target to reduce cardiovascular disease risk. Numbers above this threshold may suggest an increased likelihood of arterial plaque presence.

If your ApoB levels are high, your provider may want to order additional testing to determine whether atherosclerosis is present and to initiate treatment if indicated to help lower disease risk. ApoB can be a useful marker in these instances to track the efficacy of treatment plans.Β 

How to Lower ApoB Naturally

Effective ways exist of reducing atherosclerosis risk and ApoB levels. Diet and lifestyle modifications are often sufficient as therapeutic treatments for individuals who have mild elevations in cholesterol and ASCVD risk.Β 

Diet Modification

Diet modification is the cornerstone of cardiovascular disease treatment. For individuals with high cholesterol and who are at increased risk for atherosclerosis, the following is recommended:

  • Avoid foods with trans fats
  • Reduce saturated fat intake to less than 7% of daily dietary intake, replacing it with monounsaturated fats such as olive oilΒ 
  • Decrease sugar intake to less than 10% of total calories
  • Reduce intake of refined grains and processed meat
  • Increase and diversify vegetable intake. An easy way to do this is to β€œeat the rainbow” by incorporating vegetables of different colors, from leafy greens to red peppers and purple cabbages.Β 
  • Increase fiber intake to at least 20-30 grams per day, focusing on whole grains, legumes, and fruits and vegetablesΒ 
  • Diversify protein intake, prioritizing lean meats, seafood, legumes, eggs, seeds, and nuts.Β 

Diets that may support healthy cholesterol levels and cardiovascular health include:

The Mediterranean Diet

Inspired by the dietary patterns of Mediterranean countries, this diet focuses on high intake of fiber from vegetables, legumes and seeds, along with the inclusion of healthy fats and proteins and minimal intake of processed foods.Β 

Studies suggest that the Mediterranean Diet may improve cholesterol profiles and lower ApoB, which could support cardiovascular health and potentially reduce the risk of coronary heart disease.

DASH (Dietary Approaches to Stop Hypertension) DietΒ 

Similar to the Mediterranean Diet, the DASH Diet focuses on a high intake of vegetables, lean proteins, whole grains, and legumes while limiting saturated fats, alcohol, and processed meats. Additionally, it is meant to lower blood pressure levels which also decreases cardiovascular risk.Β 

Vegetarian and Plant-Based DietsΒ 

These diets involve higher intakes of fiber, vegetables, whole grains, and legumes, which leads to decreased LDL and lower incidence of cardiovascular disease mortality.Β 

Physical Activity

Exercise can also play a critical role in reducing cardiovascular disease risk. Multiple medical associations, including the American Heart Association (AHA) and the American Stroke Association, recommend regular physical exercise as part of a comprehensive treatment program for ASCVD. Regular exercise has been associated with:

  • Potential reductions in LDL levels and some reduction in ApoB.
  • Reduced triglyceride and total cholesterol levels.
  • Increased HDL levels.
  • Increased metabolism of body fat which results in less plaque-inducing lipids circulating through the arteries.
  • Decreased risk for diabetes, high blood pressure, and obesity, all of which can negatively impact cardiovascular health and function.Β 

To improve cardiovascular disease risk, the AHA recommends engaging in moderate aerobic exercise for 30 minutes 5 times per week or high intensity exercises for at least 25 minutes 3 times per week. To further reduce heart attack and stroke risk, 40 minutes of moderate to high intensity exercise is recommended at least 3 days per week.Β 

Supplements

In addition to diet and exercise, certain supplements may offer potential benefits as part of a comprehensive treatment plan for cardiovascular disease.Β 

Most commonly, niacin and omega 3 fatty acids are used to help improve cholesterol profiles in conjunction with statin therapy. Niacin may help increase HDL levels, while omega-3 fatty acids have been studied for their potential to improve triglyceride levels.

When to Consider a Pharmaceutical Approach

Although natural interventions can reduce ASCVD risk, pharmaceutical therapy may be required if dietary and lifestyle changes are not enough to modify cholesterol profiles and disease outcomes. To assess risk, the ASCVD risk calculator estimates the 10-year likelihood of an ASCVD event based on factors such as cholesterol numbers, blood pressure, and the presence of other risk factors.Β 

Pharmaceutical interventions may be considered when the 10-year ASCVD risk is estimated to exceed 7.5% or if other high-risk factors are present, such as LDL levels greater than 160 mg/dL, chronic kidney disease, family history of early-onset ASCVD, or metabolic disease.Β 

Commone Drug Therapies

Common drug therapies for lowering ASCVD include:

StatinsΒ 

Statins are often the first-line treatment for elevated atherosclerotic lipid levels. They are highly effective in lowering LDL levels, with reductions ranging from 20% to 50% depending on statin dose and intensity.Β 

Additionally, statins play a role in stabilizing plaques to help prevent their breakage, thereby reducing stroke risk. Downsides of statin use include increased risk for muscle pain and liver damage.Β 

Bile Acid SequestrantsΒ 

These bind to bile acids causing them to be eliminated from the body. To compensate, the liver converts cholesterol into bile acids, effectively lowering cholesterol levels. Side effects of bile acid sequestrants include constipation, loss of appetite, and indigestion.Β 

Cholesterol Absorption Inhibitors

These reduce the absorption of dietary cholesterol by inhibiting uptake at the intestinal border leading to reductions in LDL, ApoB, and total cholesterol levels. Common side effects include headache, runny nose, and sore throat.Β 

When to See Your Doctor

High cholesterol is often discovered incidentally as part of a routine screening panel on annual exam lab work. As the early stages of ASCVD can be asymptomatic, it is important to undergo regular health check-ups with your healthcare provider so that interventions can be started early if needed.Β Β 

If you are experiencing any of the following symptoms, consider consulting your doctor, as these may be associated with ASCVD:

Risk factors that should be discussed with your doctor include:

Working with your healthcare provider is critical in identifying the need for treatment and managing interventions to meet your ASCVD risk goals and be safely monitored.Β 

[signup]

Key Takeaways

  • Lowering ApoB naturally may involve a heart-healthy diet, regular exercise, and, when necessary, pharmaceutical interventions. These lifestyle changes may help support cardiovascular health and reduce plaque buildup.Β 
  • Regular monitoring of cholesterol and ApoB levels is essential to track progress.Β 
  • Managing heart health is not one-size-fits-allβ€”consult your doctor for personalized guidance and tailored interventions to effectively reduce your risk of atherosclerotic cardiovascular disease.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024, February 5). How to test and interpret total cholesterol levels: A functional medicine perspective. Rupa Health. https://www.rupahealth.com/post/how-to-test-and-interpret-total-cholesterol-levels-a-functional-medicine-perspective

Alhazmi, N. (2024). The Effectiveness of Physical Exercise in Reducing Common Risk Factors of Atherosclerosis: A Systematic Review. Cellular Physiology & Biochemistry, 58(5), 571–583. https://www.cellphysiolbiochem.com/Articles/000732/

American College of Cardiology. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. American College of Cardiology. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/03/07/16/00/2019-acc-aha-guideline-on-primary-prevention-gl-prevention

American College of Cardiology. (2021). ASCVD risk estimator. American College of Cardiology. https://tools.acc.org/ascvd-risk-estimator-plus/#

Anderson, S. (2022, May 19). 6 Preventable Risk Factors Associated With Heart Attacks. Rupa Health. https://www.rupahealth.com/post/5-things-to-do-after-a-heart-attack

ASCVD . (n.d.). Www.heart.org. Retrieved November 28, 2024, from https://www.heart.org/en/professional/quality-improvement/ascvd

Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesity

Cloyd, J. (2022, September 16). 9 Health Benefits of the DASH Diet. Www.rupahealth.com. https://www.rupahealth.com/post/9-health-benefits-of-the-dash-diet

Cloyd, J. (2023a, May 1). A Functional Medicine Protocol for Coronary Artery Disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-coronary-artery-disease

Cloyd, J. (2023b, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health. https://www.rupahealth.com/post/the-role-of-physical-activity-and-exercise-in-promoting-heart-health-including-the-use-of-alternative-exercise-modalities-such-as-tai-chi-and-qigong

Cloyd, J. (2023c, August 21). A root cause medicine protocol for patients with psoriasis: Comprehensive lab testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-psoriasis-comprehensive-lab-testing-therapeutic-diet-and-supplements

Cloyd, J. (2023d, September 12). An Integrative and Comprehensive Approach to Transient Ischemic Attacks. Rupa Health. https://www.rupahealth.com/post/an-integrative-and-comprehensive-approach-to-transient-ischemic-attacks

Cloyd, J. (2023e, December 4). Omega-3 Fatty Acids in Cardiovascular Health: A Functional Medicine Guide. Rupa Health. https://www.rupahealth.com/post/omega-3-fatty-acids-in-cardiovascular-health-a-functional-medicine-guide

Cloyd, J. (2024a, February 28). The Link Between Erectile Dysfunction and Cardiovascular Disease: Understanding the Connection. Rupa Health. https://www.rupahealth.com/post/the-link-between-erectile-dysfunction-and-cardiovascular-disease-understanding-the-connection

Cloyd, J. (2024b, March 4). The Role of Statins in Managing High Cholesterol: Benefits and Side Effects. Rupa Health. https://www.rupahealth.com/post/the-role-of-statins-in-managing-high-cholesterol-benefits-and-side-effects

Cloyd, J. (2024c, March 5). How to lower LDL cholesterol naturally: Evidence-Based recommendations. Rupa Health. https://www.rupahealth.com/post/how-to-lower-ldl-cholesterol-naturally-evidence-based-recommendations

Cloyd, J. (2024d, June 20). Understanding Heart Palpitations: Causes, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-heart-palpitations-causes-diagnosis-and-treatment

Cloyd, J. (2024e, August 29). High Blood Pressure: Comprehensive Guide for Practitioners and Patients. Rupa Health. https://www.rupahealth.com/post/high-blood-pressure-comprehensive-guide-for-practitioners-and-patients

Cloyd, K. (2023, December 7). Cardiovascular Disease and Metabolic Syndrome: Addressing Root Causes with Functional Medicine. Rupa Health. https://www.rupahealth.com/post/cardiovascular-disease-and-metabolic-syndrome-addressing-root-causes-with-functional-medicine

Creedon, K. (2022, May 26). How To Naturally Relieve Rheumatoid Arthritis Pain. Rupa Health. https://www.rupahealth.com/post/natural-treatments-for-rheumatoid-arthritis-pain

Daglis, S. (2024, September 4). The Health Impact of Plant-Based Diets: Cardiovascular and Cancer Risk Reduction. Rupa Health. https://www.rupahealth.com/post/the-health-impact-of-plant-based-diets-cardiovascular-and-cancer-risk-reduction

Devaraj, S., Semaan, J. R., & Jialal, I. (2020). Biochemistry, Apolipoprotein B. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538139/

Diorio, B. (2023, April 7). Could your patients benefits from the phytonutrient spectrum food plan? Rupa Health. https://www.rupahealth.com/post/could-your-patients-benefits-from-the-phytonutrient-spectrum-food-plan

Fogelstrand, P., & BorΓ©n, J. (2012). Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutrition, Metabolism and Cardiovascular Diseases, 22(1), 1–7. https://doi.org/10.1016/j.numecd.2011.09.007

Gordon, S. M., Amar, M. J., Jeiran, K., Stagliano, M., Staller, E., Playford, M. P., Mehta, N. N., Vaisar, T., & Remaley, A. T. (2020). Effect of niacin monotherapy on high density lipoprotein composition and function. Lipids in Health and Disease, 19(1). https://doi.org/10.1186/s12944-020-01350-3

Gotto, A., & Opie, L. (2009). Lipid-Modifying and Antiatherosclerotic Drugs. Drugs for the Heart, 341–372. https://doi.org/10.1016/B978-1-4160-6158-8.50015-0

Holme, I., HΓΈstmark, A. T., & Anderssen, S. A. (2007). ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. Journal of Internal Medicine, 262(2), 235–243. https://doi.org/10.1111/j.1365-2796.2007.01806.x

Kaur, G., R Preston Mason, Ph Gabriel Steg, & Bhatt, D. L. (2024). Omega-3 fatty acids for cardiovascular event lowering. European Journal of Preventive Cardiology, 31(8), 1005–1014. https://doi.org/10.1093/eurjpc/zwae003

Khakham, C. (2023a, March 28). An integrative medicine approach to kidney disease. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-kidney-disease

Khakham, C. (2023b, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Lent-Schochet, D., & Jialal, I. (2021). Antilipemic Agent Bile Acid Sequestrants. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549906/

Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233–241. https://doi.org/10.1038/35025203

National Heart, Lung And Blood Institute. (2022, March 24). Atherosclerosis - Causes and Risk Factors | NHLBI, NIH. Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/health/atherosclerosis/causes

National Heart, Lung, and Blood Institute. (2022, March 24). Atherosclerosis - Symptoms | NHLBI, NIH. Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/health/atherosclerosis/symptoms

National Research Council (US) Committee on Diet and Health. (2017). Fats and Other Lipids. Nih.gov; National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK218759/

Perera, H. (2024, April 11). The Ultimate Fiber Foods List: Boost Your Health with High-Fiber Choices. Rupa Health. https://www.rupahealth.com/post/ultimate-fiber-foods-list

Preston, J. (2022, November 10). What’s The Difference Between Good And Bad Dietary Fat? Rupa Health. https://www.rupahealth.com/post/dietary-fat-the-good-the-bad-and-the-misunderstood

Preston, J. (2023, July 20). An Integrative Comprehensive Approach to Preeclampsia: Risk Factors and Preventative Lab Testing. Rupa Health. https://www.rupahealth.com/post/an-integrative-comprehensive-approach-to-preeclampsia-risk-factors-and-preventative-lab-testing

Rupa Health. (n.d.-a). High-Density Lipoprotein Cholesterol. Rupa Health. Retrieved November 25, 2024, from https://www.rupahealth.com/biomarkers/hdl

Rupa Health. (n.d.-b). Low-Density Lipoprotein Cholesterol. Rupa Health. Retrieved November 25, 2024, from https://www.rupahealth.com/biomarkers/ldl

Rupa Health. (n.d.-c). Total Cholesterol. Rupa Health. Retrieved November 25, 2024, from https://www.rupahealth.com/biomarkers/total-cholesterol-d8055

Rupa Health. (n.d.-d). Triglycerides. Rupa Health. Retrieved November 25, 2024, from https://www.rupahealth.com/biomarkers/triglycerides

Rupa Health. (n.d.-e). Very Low-Density Lipoproteins. Rupa Health. Retrieved November 28, 2024, from https://www.rupahealth.com/biomarkers/vldl

Rupa Magazine. (2020). Apolipoprotein B | Rupa Health. Rupa Health. https://www.rupahealth.com/biomarkers/apo-b?utm_source=google&utm_medium=cpc&utm_campaign=20893116874&utm_content=&utm_term=&gad_source=1&gclid=CjwKCAjw1920BhA3EiwAJT3lSWKSRmEJn6l5YHL9sS6zO5uLsIuIobeT_GviT69IV0eZj6rNipvWgRoC8-QQAvD_BwE

SADOVSKY, R. (2003). Using Apolipoprotein B Levels to Assess Cardiac Risk. American Family Physician, 67(6), 1386–1386. https://www.aafp.org/pubs/afp/issues/2003/0315/p1386.html

Shapiro, M. D., & Fazio, S. (2017). Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Research, 6, 134. https://doi.org/10.12688/f1000research.9845.1

Sizar, O., & Talati, R. (2020). Ezetimibe. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532879/

SolΓ‘, R., FitΓ³, M., Estruch, R., Salas-SalvadΓ³, J., Corella, D., de La Torre, R., MuΓ±oz, M. A., del Carmen LΓ³pez-Sabater, M., MartΓ­nez-GonzΓ‘lez, M.-A., ArΓ³s, F., Ruiz-Gutierrez, V., Fiol, M., Casals, E., WΓ€rnberg, J., Buil-Cosiales, P., Ros, E., Konstantinidou, V., Lapetra, J., Serra-Majem, L., & Covas, M.-I. (2011). Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: A randomized, controlled trial. Atherosclerosis, 218(1), 174–180. https://doi.org/10.1016/j.atherosclerosis.2011.04.026

Stanford, J. (2024a, February 20). Navigating the trans fat terrain: Strategies for healthcare professionals to protect patient health. Rupa Health. https://www.rupahealth.com/post/navigating-the-trans-fat-terrain-strategies-for-healthcare-professionals-to-protect-patient-health

Stanford, J. (2024b, May 31). How protein affects metabolism: Impacts and insights. Rupa Health. https://www.rupahealth.com/post/how-protein-affects-metabolism-impacts-and-insights

Sweetnich, J. (2023a, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Sweetnich, J. (2023b, May 4). How to Make Sure Your Patients Are Getting Enough Vitamin B3 (Niacin) in Their Diet: Testing, RDAs, and Supplementing. Rupa Health. https://www.rupahealth.com/post/vitamin-b3-niacin-101-testing-rdas-and-supplementing

Tian, D., & Meng, J. (2019). Exercise for Prevention and Relief of Cardiovascular Disease: Prognoses, Mechanisms, and Approaches. Oxidative Medicine and Cellular Longevity, 2019(3756750), 1–11. https://doi.org/10.1155/2019/3756750

Weinberg, J. (2022, November 16). 4 Science Backed Health Benefits of The Mediterranean Diet. Rupa Health. https://www.rupahealth.com/post/4-science-backed-health-benefits-of-the-mediterranean-diet

Yurth, E. (2021, July 20). How to Identify Risk for Cardiovascular Disease Using ApoB/ApoA1 Blood Testing. Rupa Health. https://www.rupahealth.com/post/how-to-identify-risk-for-cardiovascular-disease-using-apob-apoa1-blood-testing

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Cardiology
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.